Journal
STEM CELL RESEARCH
Volume 50, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.scr.2020.102033
Keywords
-
Funding
- funding program for Research Center Network for Realization of Regenerative Medicine from Agency for Medical Research and Development (AMED)
Ask authors/readers for more resources
The Induced Pluripotent Stem Cell (iPSC) Stock Project in Japan, which started in 2013, aims to produce and release clinical-grade HLA homozygous iPSC lines that can cover almost the entire Japanese population. The project has already begun distributing cell lines, conducting quality control tests, and has future plans in place.
In Japan, induced pluripotent stem cell (iPSC) Stock Project has started from 2013. The goal of the Project is to manufacture and release clinical-grade HLA homozygous iPSC lines that can cover almost the entire of Japanese population. We show the summary of the cell lines distributed, test results for quality control and future plans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
